These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32243964)

  • 21. Characterization and monitoring of pseudo-polymorphs in manufacturing process by NIR.
    Kamada K; Yoshimura S; Murata M; Murata H; Nagai H; Ushio H; Terada K
    Int J Pharm; 2009 Feb; 368(1-2):103-8. PubMed ID: 19007870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3D simulation of internal tablet strength during tableting.
    Siiriä SM; Antikainen O; Heinämäki J; Yliruusi J
    AAPS PharmSciTech; 2011 Jun; 12(2):593-603. PubMed ID: 21541828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Demonstration of Mixing Robustness in a Direct Compression Continuous Manufacturing Process.
    Roth WJ; Almaya A; Kramer TT; Hofer JD
    J Pharm Sci; 2017 May; 106(5):1339-1346. PubMed ID: 28153598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability and repeatability of a continuous twin screw granulation and drying system.
    Vercruysse J; Delaet U; Van Assche I; Cappuyns P; Arata F; Caporicci G; De Beer T; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1031-8. PubMed ID: 23702273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lubricant sensitivity in function of paddle movement in the forced feeder of a high-speed tablet press.
    Peeters E; Vanhoorne V; Vervaet C; Remon JP
    Drug Dev Ind Pharm; 2016 Dec; 42(12):2078-2085. PubMed ID: 27277525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the effect of granule size of raw tableting materials on critical quality attributes of tablets during the continuous tablet manufacturing process using near-infrared spectroscopy.
    Otsuka M; Ogata T; Hattori Y; Sasaki T
    Drug Dev Ind Pharm; 2023 Nov; 49(11):692-702. PubMed ID: 37847490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Critical Material Attributes (CMAs)-Particle Shape on Miniature Pharmaceutical Unit Operations.
    Azad MA; Capellades G; Wang AB; Klee DM; Hammersmith G; Rapp K; Brancazio D; Myerson AS
    AAPS PharmSciTech; 2021 Mar; 22(3):98. PubMed ID: 33709195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Image-based characterization of powder flow to predict the success of pharmaceutical minitablet manufacturing.
    Blanco D; Antikainen O; Räikkönen H; Mah PT; Healy AM; Juppo AM; Yliruusi J
    Int J Pharm; 2020 May; 581():119280. PubMed ID: 32229285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automatic system dynamics characterization of a pharmaceutical continuous production line.
    Jelsch M; Roggo Y; Mohamad A; Kleinebudde P; Krumme M
    Eur J Pharm Biopharm; 2022 Nov; 180():137-148. PubMed ID: 36122784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microcrystalline cellulose and its microstructure in pharmaceutical processing.
    Westermarck S; Juppo AM; Kervinen L; Yliruusi J
    Eur J Pharm Biopharm; 1999 Nov; 48(3):199-206. PubMed ID: 10612030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi-scale flowsheet simulation of an integrated continuous purification-downstream pharmaceutical manufacturing process.
    Sen M; Chaudhury A; Singh R; John J; Ramachandran R
    Int J Pharm; 2013 Mar; 445(1-2):29-38. PubMed ID: 23380627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of physical mixtures and directly compressed tablets of sulfamerazine polymorphs: implications on in vitro release characteristics.
    Roy S; Alexander KS; Riga AT; Chatterjee K
    J Pharm Sci; 2003 Apr; 92(4):747-59. PubMed ID: 12661061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spectroscopic characterization of tablet properties in a continuous powder blending and tableting process.
    Nagy B; Farkas A; Magyar K; Démuth B; Nagy ZK; Marosi G
    Eur J Pharm Sci; 2018 Oct; 123():10-19. PubMed ID: 30017844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous Feeding and Blending Demonstration with Co-Processed Drug Substance.
    Erdemir D; Gawel J; Yohannes B; Yates P; Tang D; Ha K; Breza B; DiMaso E; Abebe A; Zombek J
    J Pharm Sci; 2023 Aug; 112(8):2046-2056. PubMed ID: 36462708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simplified end-to-end continuous manufacturing by feeding API suspensions in twin-screw wet granulation.
    Schmidt A; de Waard H; Moll KP; Kleinebudde P; Krumme M
    Eur J Pharm Biopharm; 2018 Dec; 133():224-231. PubMed ID: 30291963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous direct compression as manufacturing platform for sustained release tablets.
    Van Snick B; Holman J; Cunningham C; Kumar A; Vercruysse J; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2017 Mar; 519(1-2):390-407. PubMed ID: 28069390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the influence of raw material attributes on process behaviour and product quality in a continuous WET granulation tableting line.
    Zupančič O; Doğan A; Martins Fraga R; Demiri V; Paudel A; Khinast J; Spoerk M; Sacher S
    Int J Pharm; 2023 Jul; 642():123097. PubMed ID: 37268028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges encountered in the transfer of atorvastatin tablet manufacturing - commercial batch-based production as a basis for small-scale continuous tablet manufacturing tests.
    Lyytikäinen J; Kyllönen S; Ervasti T; Komulainen E; Pekarek T; Slunečková J; Leskinen J; Ketolainen J; Kubelka T; Stasiak P; Korhonen O
    Int J Pharm; 2023 Nov; 647():123509. PubMed ID: 37832703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-Time Monitoring of Powder Mass Flowrates for Plant-Wide Control of a Continuous Direct Compaction Tablet Manufacturing Process.
    Huang YS; Medina-González S; Straiton B; Keller J; Marashdeh Q; Gonzalez M; Nagy Z; Reklaitis GV
    J Pharm Sci; 2022 Jan; 111(1):69-81. PubMed ID: 34126119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of raw material properties upon critical quality attributes of continuously produced granules and tablets.
    Fonteyne M; Wickström H; Peeters E; Vercruysse J; Ehlers H; Peters BH; Remon JP; Vervaet C; Ketolainen J; Sandler N; Rantanen J; Naelapää K; De Beer T
    Eur J Pharm Biopharm; 2014 Jul; 87(2):252-63. PubMed ID: 24589422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.